Amgen completes acquisition of Mustafa Nevzat Pharmaceuticals

Amgen (NASDAQ: AMGN) today announced the completion of the acquisition of more than 99 percent of the shares of Mustafa Nevzat Pharmaceuticals, a privately held Turkish company.

The all-cash transaction significantly expands Amgen’s presence in Turkey and the surrounding region, which includes several fast-growing, priority markets for Amgen. The acquisition was initially announced on April 25.